drugset / Trial / NCT01846429
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
Phase 1
Terminated
9 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Reliable Cancer Therapies · collab
NaSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to: * Determine how well people tolerate sodium bicarbonate taken by mouth in higher doses than those usually given for heartburn. * Determine if sodium bicarbonate can reduce cancer-related pain.
Timeline
- Start
- 2013-09
- Primary completion
- 2014-12
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 9000 mg | Oral |
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 18000 mg | Oral |
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 27000 mg | Oral |
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 36000 mg | Oral |